U.S. Markets close in 4 hrs 42 mins

Canopy Growth (CGC) in Focus: Stock Moves 9.2% Higher

Zacks Equity Research
1 / 2

New Strong Sell Stocks for November 2nd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Canopy Growth Corporation CGC was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 32.8% in the past one-month time frame.

The move came after Constellation Brands Inc. said it will invest around $4 billion in the company.

The company has seen no estimate revisions over the past few weeks and the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Canopy Growth currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

Canopy Growth Corporation Price

Canopy Growth Corporation Price | Canopy Growth Corporation Quote

A better-ranked stock in the Medical - Products industry is BioLife Solutions, Inc. BLFS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CGC going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.